United States HR 5882: GENE Therapy Payment Act

Status: Introduced in House (as of 2020-02-12)

State: United States · Session: 116 · Bill: HR 5882

Subjects: Administrative law and regulatory procedures, Appropriations, Congressional oversight, Department of Health and Human Services, Drug safety, medical device, and laboratory regulation, Drug therapy, Genetics, Government studies and investigations, Health care costs and insurance, Home and outpatient care, Intergovernmental relations, Manufacturing, Medicaid, Prescription drugs, State and local government operations

Sponsors: Kurt Schrader, Ami Bera, David Schweikert, Jason Crow, Markwayne Mullin, Mike Kelly, Roger W. Marshall

View United States HR 5882 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.